Anne D. Fine

6.8k total citations · 3 hit papers
18 papers, 3.7k citations indexed

About

Anne D. Fine is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Anne D. Fine has authored 18 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Epidemiology. Recurrent topics in Anne D. Fine's work include Influenza Virus Research Studies (5 papers), Mosquito-borne diseases and control (4 papers) and Respiratory viral infections research (3 papers). Anne D. Fine is often cited by papers focused on Influenza Virus Research Studies (5 papers), Mosquito-borne diseases and control (4 papers) and Respiratory viral infections research (3 papers). Anne D. Fine collaborates with scholars based in United States and United Kingdom. Anne D. Fine's co-authors include Edward M. Eitzen, Thomas V. Inglesby, Michael T. Osterholm, Trish M. Perl, Kevin Tonat, Michael S. Ascher, Jerome Hauer, Gerald Parker, John G. Bartlett and Scott R. Lillibridge and has published in prestigious journals such as JAMA, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Anne D. Fine

18 papers receiving 3.6k citations

Hit Papers

Botulinum Toxin as a Biological Weapon 2000 2026 2008 2017 2001 2001 2000 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne D. Fine United States 12 1.9k 1.3k 920 727 512 18 3.7k
Scott R. Lillibridge United States 19 1.9k 1.0× 946 0.7× 922 1.0× 749 1.0× 438 0.9× 35 4.0k
Marcelle Layton United States 5 2.3k 1.2× 1.3k 1.0× 925 1.0× 718 1.0× 298 0.6× 6 3.6k
Gerald Parker United States 10 4.0k 2.1× 2.3k 1.8× 961 1.0× 1.1k 1.5× 473 0.9× 14 5.9k
Kevin Tonat United States 11 4.1k 2.1× 2.2k 1.7× 932 1.0× 1.2k 1.6× 421 0.8× 12 5.9k
Donald A. Henderson United States 21 2.6k 1.4× 1.3k 1.0× 960 1.0× 1.1k 1.5× 827 1.6× 51 5.3k
Edward M. Eitzen United States 19 4.5k 2.3× 2.4k 1.8× 933 1.0× 1.4k 1.9× 539 1.1× 30 6.6k
Saskia L. Smits Netherlands 34 460 0.2× 509 0.4× 319 0.3× 3.5k 4.9× 1.1k 2.1× 71 4.8k
Neal Nathanson United States 45 751 0.4× 640 0.5× 178 0.2× 3.0k 4.1× 1.6k 3.1× 166 6.3k
Julian A. Hiscox United Kingdom 43 1.7k 0.9× 1.1k 0.8× 233 0.3× 3.0k 4.2× 1.0k 2.0× 145 5.5k
Adam S. Lauring United States 36 1.4k 0.7× 823 0.6× 162 0.2× 2.6k 3.6× 1.3k 2.5× 98 5.1k

Countries citing papers authored by Anne D. Fine

Since Specialization
Citations

This map shows the geographic impact of Anne D. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne D. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne D. Fine more than expected).

Fields of papers citing papers by Anne D. Fine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne D. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne D. Fine. The network helps show where Anne D. Fine may publish in the future.

Co-authorship network of co-authors of Anne D. Fine

This figure shows the co-authorship network connecting the top 25 collaborators of Anne D. Fine. A scholar is included among the top collaborators of Anne D. Fine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne D. Fine. Anne D. Fine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chan, Pui Ying, et al.. (2021). Persistent disparities in SARS-CoV-2 test percent positivity by neighborhood in New York City, March 1–July 25, 2020. Annals of Epidemiology. 63. 46–51. 5 indexed citations
2.
Thompson, Corinne N., Scott Hughes, Stephanie Ngai, et al.. (2021). Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant — New York City, New York, January 1–April 5, 2021. MMWR Morbidity and Mortality Weekly Report. 70(19). 712–716. 36 indexed citations
3.
Yang, Wan, Sasikiran Kandula, Mary Huynh, et al.. (2020). Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. The Lancet Infectious Diseases. 21(2). 203–212. 115 indexed citations
4.
Cooper, Hannah, Martha Iwamoto, Maura K. Lash, et al.. (2019). Maternal Zika Virus Infection. Obstetrics and Gynecology. 134(6). 1197–1204. 11 indexed citations
5.
Newsome, Kimberly, C.J. Alverson, Jennifer Williams, et al.. (2019). Outcomes of infants born to women with influenza A(H1N1)pdm09. Birth Defects Research. 111(2). 88–95. 31 indexed citations
6.
Conners, Erin E., Ellen H. Lee, Corinne N. Thompson, et al.. (2018). Zika Virus Infection Among Pregnant Women and Their Neonates in New York City, January 2016–June 2017. Obstetrics and Gynecology. 132(2). 487–495. 14 indexed citations
7.
Lee, Christopher T., Sharon K. Greene, Jennifer Baumgartner, & Anne D. Fine. (2017). Disparities in Zika Virus Testing and Incidence Among Women of Reproductive Age—New York City, 2016. Journal of Public Health Management and Practice. 24(6). 533–541. 7 indexed citations
8.
Benowitz, Isaac, Joel Ackelsberg, Sharon Balter, et al.. (2014). Surveillance and preparedness for Ebola virus disease -- New York City, 2014.. PubMed. 63(41). 934–6. 13 indexed citations
9.
Ackelsberg, Joel, Sharon Balter, Jennifer Baumgartner, et al.. (2014). Surveillance and Preparedness for Ebola Virus Disease—New York City, 2014. American Journal of Transplantation. 15(1). 278–280. 10 indexed citations
10.
Westheimer, Emily, Marc Paladini, Sharon Balter, et al.. (2012). Evaluating the New York City Emergency Department Syndromic Surveillance for Monitoring Influenza Activity during the 2009-10 Influenza Season. PLoS Currents. 4. e500563f3ea181–e500563f3ea181. 11 indexed citations
11.
Creanga, Andreea A., Samuel B. Graitcer, Teeb Al‐Samarrai, et al.. (2010). Severity of 2009 Pandemic Influenza A (H1N1) Virus Infection in Pregnant Women. Obstetrics and Gynecology. 115(4). 717–726. 248 indexed citations
12.
Hadler, James L., Kevin Konty, Katharine H. McVeigh, et al.. (2010). Case Fatality Rates Based on Population Estimates of Influenza-Like Illness Due to Novel H1N1 Influenza: New York City, May–June 2009. PLoS ONE. 5(7). e11677–e11677. 36 indexed citations
13.
Skupski, Daniel, Gary S. Eglinton, Anne D. Fine, Edward B. Hayes, & Daniel R. O’Leary. (2006). West Nile Virus during Pregnancy: A Case Study of Early Second Trimester Maternal Infection. Fetal Diagnosis and Therapy. 21(3). 293–295. 5 indexed citations
14.
Arnon, Stephen S., Robert Schechter, Thomas V. Inglesby, et al.. (2001). Botulinum toxin as a biological weapon. JAMA. 285(8). 95 indexed citations
15.
Dennis, David T., Thomas V. Inglesby, John G. Bartlett, et al.. (2001). Tularemia as a Biological Weapon. JAMA. 285(21). 2763–2763. 1020 indexed citations breakdown →
16.
Fine, Anne D., Carolyn B. Bridges, Louise Glover, et al.. (2001). Influenza A among Patients with Human Immunodeficiency Virus: An Outbreak of Infection at a Residential Facility in New York City. Clinical Infectious Diseases. 32(12). 1784–1791. 86 indexed citations
17.
Arnon, S. S., Robert Schechter, Thomas V. Inglesby, et al.. (2001). Botulinum Toxin as a Biological Weapon. JAMA. 285(8). 1059–1059. 1297 indexed citations breakdown →
18.
Inglesby, Thomas V., David T. Dennis, Donald A. Henderson, et al.. (2000). Plague as a Biological Weapon. JAMA. 283(17). 2281–2281. 708 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026